When adjusting for potential confounders, on a continuous scale, each decrease in albumin level was associated with an elevated risk of cancer-related mortality across all patient groups [all cancers, HR (95%CI) = 2.03(1.73, 2.37); well survived cancers, HR (95%CI) = 1.78(1.38, 2.32); and poorly survived cancers, HR (95%CI) = 1.99(1.64, 2.42)] (Table 2). This evidence concerns the gene ALB and cancer.